Frontlight ResearchEarly access
Cystic fibrosis trials in Netherlands
5 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleDrug-drug interaction study of midazolam and brensocatib
- Where
- Groningen
- Age
- 18 years to 64 years
- People
- 26
- Run by
- Insmed Inc.
See details and how to join2026-526670-16-00 - Phase 2Not yet taking people in NetherlandsDose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Where
- Alkmaar, Amsterdam, Eindhoven, Hoofddorp, Nijmegen, Rotterdam, Zutphen
- Age
- 18 years to 85 years
- People
- 180 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00 - Phase 2SuspendedSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
- Where
- 's-Gravenhage
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Splisense Ltd.
See details and how to join2024-511184-28-00 - Phase 2Not yet taking people in NetherlandsSafety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
- Where
- Amsterdam, Nijmegen, 's-Gravenhage
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Vertex Pharmaceuticals Inc.
See details and how to join2025-523400-72-00 - Phase 3Taking peopleEvaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older
- Where
- Rotterdam
- Age
- 1 year to 17 years
- People
- 174 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT05844449 · EU 2022-503081-74-00